Neuropsychiatric adverse events in people with HIV initiating a new integrase strand transfer inhibitor-based regimen in Italy: findings from the NEURO-INSTI study
Abstract Background Although clinical trials reported a low and comparable rate of central nervous system (CNS)/neuropsychiatric (NP) disturbances among people with HIV (PWH) receiving integrase strand transfer inhibitors (INSTI) or other antiretroviral therapy (ART), higher rates of these disturban...
Saved in:
| Main Authors: | Nicola Squillace, Elena Delfina Ricci, Giancarlo Orofino, Gabriele Forcina, Laura Albini, Barbara Menzaghi, Giuseppe Vittorio De Socio, Stefania Piconi, Paolo Maggi, Giordano Madeddu, Giovanni Francesco Pellicanò, Eleonora Sarchi, Benedetto Maurizio Celesia, Filippo Lagi, Elena Salomoni, Antonio Di Biagio, Paolo Bonfanti |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-05-01
|
| Series: | BMC Infectious Diseases |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12879-025-11090-3 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Role of low-frequency integrase strand transfer inhibitor resistance mutations on virological outcomes in antiretroviral therapy-naïve individuals initiating second-generation integrase inhibitors
by: Daniele Armenia, et al.
Published: (2025-06-01) -
From protease inhibitors to integrase strand transfer inhibitors: the evolution of HIV drug resistance management
by: HU Zhiliang, YANG Yongfeng
Published: (2025-01-01) -
Outcomes of switching from protease inhibitor-based antiretroviral therapy to bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in virologically suppressed adults with nucleos(t)ide analogue resistance– a phase IV randomised, open-label study (PIBIK study)
by: Collins Iwuji, et al.
Published: (2025-02-01) -
Switching to bictegravir/emtricitabine/tenofovir alafenamide from efavirenz/emtricitabine/tenofovir disoproxil in virologically suppressed people with HIV: findings from a non-randomized clinical trial (EBONY study)
by: Roberta Gagliardini, et al.
Published: (2025-09-01) -
Confronting Dual Therapeutic Hurdles in Advanced HIV: A Case Report on INSTIs Resistance and Talaromyces marneffei Coinfection
by: Zou L, et al.
Published: (2025-08-01)